Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Medical Research Archives|February 7, 2025
Osteosarcoma: A comprehensive review of model systems and experimental therapiesGabrielle M Robbins, Young Y Vue, Eric P Rahrmann, et al.Journal of Human Genetics|November 22, 2017
CRISPR/Cas9 library screening for drug target discoveryMorito Kurata, Kouhei Yamamoto, Branden S Moriarity, et al.Physical Biology|February 17, 2026
Mechanistic modeling predicts efficacy of CISH knockout in tumor-infiltrating lymphocytes with synergistic gene editingNikolaos Memmos, Kamran Kaveh, Beau R Webber, et al.Biorxiv : the Preprint Server for Biology|September 18, 2025
Mathematical model of CISH knockout predicts increased efficacy in tumor-infiltrating lymphocyte activation with synergistic gene editingNikolaos Memmos, Kamran Kaveh, Beau R Webber, et al.Scientific Reports|August 16, 2018
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted NucleaseMatthew J Johnson, Kanut Laoharawee, Walker S Lahr, et al.Frontiers in Immunology|December 5, 2025
Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risksScott L Baughan, Timothy Folsom, Matt Johnson, et al.Methods in Molecular Biology (Clifton, N.J.)|July 31, 2020
C-to-U RNA Editing: From Computational Detection to Experimental ValidationTaga Lerner, Mitchell Kluesner, Rafail Nikolaos Tasakis, et al.Cytotherapy|January 12, 2023
CRISPR-Cas9 base editors and their current role in human therapeuticsWalker S Lahr, Christopher J Sipe, Joseph G Skeate, et al.Frontiers in Immunology|February 2, 2026
Correction: Perspective: IL-15 cytokine-armored NK cells as ready-to-use immunotherapy for diverse malignancies: therapeutic potential and toxicity risksScott L Baughan, Timothy Folsom, Matt Johnson, et al.Progress in Molecular Biology and Translational Science|June 27, 2021
Targeted genome editing for the correction or alleviation of primary ImmunodeficienciesChristopher J Sipe, Patricia N Claudio Vázquez, Joseph G Skeate, et al.Pageof 12